India In Vitro Fertilization (IVF) Services Market By Gender (Male, Female and Others) by Procedure (ICSI IVF, Non-ICSI IVF and IUI) by Cycle Type (Fresh IVF Cycles, Thawed IVF Cycles and Donor Egg IVF Cycles) by End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes) and Offering (IVF Drugs, IVF Media & Reagents and IVF and IUI Services): India Opportunity Analysis and Industry Forecast, 2018-2026
- ALL3347157
- 127 Pages
- October 2019
- Healthcare
In vitro fertilization (IVF) is a type of assisted reproductive technology. In this technique the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is one of the widely used treatments, which is used for the assistance of couples with infertility problems, single mothers, and the LGBT community to procreate. The delayed pregnancy in women is one of the major driving factors of the IVF services market, as the chances of conceiving decrease with age. However, the success rate of IVF technique is higher in the age group of 35–39 years.
The India IVF services market is expected to witness significant growth during the forecast period owing to increase in infertility rates caused due to rise in stress levels, changes in lifestyle, and surge in incidence of fertility-related diseases. Low awareness toward this technique in the society restricts the market growth. Rising prevalence due to increasing risk factors, such as obesity, stress, polycystic ovarian syndrome (PCOS), sexually transmitted infections, endometrial tuberculosis, and other medical conditions, is expected to offer lucrative opportunities for the market growth during the forecast period.
The India IVF market is segmented based on gender, procedure, offering, cycle type, and end user. Based on gender, it is divided into female infertility, male infertility, and both (combined) infertility. Based on procedure, it is classified into intracytoplasmic sperm injection (ICSI-IVF), non-ICSI-IVF, and intrauterine insemination (IUI). The offering segment includes drugs, media & reagents, and services.
Based on cycle type, the market is categorized into fresh cycle (non-donor), thawed cycle (non-donor), and donor egg IVF cycle. Based on end user, it is segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes.
The prominent companies, hospitals, surgical centers, fertility centers, and clinical research institutes profiled in this report include Sun Pharmaceuticals Industries Ltd., Lab IVF Asia Pte. Ltd., LG Life Sciences, Cadila Pharmaceuticals Ltd., Bourn Hall Clinic, Morpheus Life Sciences Pvt. Ltd., Southend Fertility and IVF Centre, Nova IVI Fertility, Bloom Fertility Center, Manipalankur Andrology and Reproductive Medicine, Cloudnine Hospitals, Gunasheela Hospital Mathrutva Fertility Centre (A Unit Of Max HealthCare Pvt. Ltd.) Milann, and Oasis Center (a unit of the entity Sadguru Healthcare Services Pvt. Ltd.)
KEY MARKET BENEFITS
• The study provides an in-depth analysis of the India IVF services market along with the current trends and future estimations to elucidate the imminent investment pockets.
• The report presents a quantitative analysis of the market from 2018 to 2026 to enable stakeholders to capitalize on the prevailing market opportunities.
• An extensive analysis of the market based on application assists to understand the trends in the industry.
• The key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry.
KEY MARKET SEGMENTS
By Gender
o Female
o Male
o other
By Procedure
o ICSI-IVF
o Non-ICSI IVF
o IUI
By Cycle Type
o Fresh IVF Cycles
o Thawed IVF Cycles
o Donor Egg IVF Cycles
By End User
o Fertility Clinics
o Hospitals
o Surgical Centers
o Clinical Research Institutes
By Offering
o IVF Drugs
o IVF Media & Reagents
o IVF and IUI Services
LIST OF KEY PLAYERS PROFILED IN THE REPORT
o Gunasheela Hospital
o Mathrutva Fertility Centre (unit of max healthcare Pvt. Ltd.)
o Milann-The Fertility Center
o Oasis Centre
o Sun Pharmaceutical Industries Ltd.
o LabIVF Asia Pte. Ltd.
o LG Life Sciences Ltd.
o Cadila Pharmaceuticals Limited
o Bourn Hall Clinic
o Morpheus Life Sciences Pvt.
o Southend Fertility and IVF Centre
o Nova IVI Fertility
o Nova IVI Fertility
o Manipal fertility hospital
o Cloudnine Hospitals
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2: Executive Summary
2.1. Key Findings of The Study
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Overview
3.3. Market Size And Forecast
3.4. Regulatory Issues, Legislations, And Authorities
3.5. Insurance Reimbursement Scenario
3.6. An Overview of Ivf Services Across Key Metro Cities In India
3.7. Qualitative Study On Rise In Ivf Services In India
3.8. India Ivf Market, By Patient Pool And Patient Conversion Rate
3.9. Indian Landscape On Key Ivf Centers
3.10. Key Impacting Factors
3.10.1. Drivers
3.10.1.1. Impact Analysis of Drivers
3.10.2. Restraints
3.10.2.1. Impact Analysis of Restraints
Chapter 4: India Ivf Services Market, By Gender
4.1. Overview
4.2. Market Size And Forecast
4.3. Female Infertility
4.3.1. Market Size And Forecast
4.4. Male Infertility
4.4.1. Market Size And Forecast
4.5. Both
4.5.1. Market Size And Forecast
Chapter 5: India Ivf And Iui Services Market, By Procedure
5.1. Overview
5.2. Market Size And Forecast
5.3. Icsi Ivf
5.3.1. Market Size And Forecast
5.4. Non-Icsi Ivf
5.4.1. Market Size And Forecast
5.5. Iui
5.5.1. Market Size And Forecast
Chapter 6: India Ivf Services Market, By Cycle Type
6.1. Overview
6.2. Market Size And Forecast
6.3. Fresh Ivf Cycles (Non-Donor)
6.4. Thawed Ivf Cycles
6.4.1. Market Size And Forecast
6.5. Donor Egg Ivf Cycles
6.5.1. Market Size And Forecast
Chapter 7: India Ivf Services Market, By End User
7.1. Overview
7.2. Market Size And Forecast
7.3. Fertility Clinics
7.3.1. Market Size And Forecast
7.4. Hospitals
7.4.1. Market Size And Forecast
7.5. Surgical Centers
7.5.1. Market Size And Forecast
7.6. Clinical Research Institutes
7.6.1. Market Size And Forecast
Chapter 8: India Ivf Market, By offering
8.1. Overview
8.2. Market Size And Forecast
8.3. Ivf Drugs
8.3.1. Market Size And Forecast
8.4. Ivf Media And Reagents
8.4.1. Market Size And Forecast
8.5. Ivf And Iui Services
8.5.1. Market Size And Forecast
Chapter 9: Company Profiles
9.1. Gunasheela Hospital
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Operating Business Segments:
9.1.4. Product Portfolio
9.1.5. Key Strategic Moves And Developments
9.2. Mathrutva Fertility Centre (Unit of Max Healthcare Pvt. Ltd.)
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Operating Business Segments:
9.2.4. Product Portfolio
9.3. Milann- The Fertility Center
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Operating Business Segments:
9.3.4. Product Portfolio
9.3.5. Key Strategic Moves And Developments
9.4. Oasis Centre (Unit of The Entity Sadguru Healthcare Services Pvt. Ltd.)
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Operating Business Segments
9.4.4. Product Portfolio
9.5. Sun Pharmaceutical Industries Ltd.
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Operating Business Segments
9.5.4. Product Portfolio
9.5.5. Business Performance
9.6. Labivf Asia Pte. Ltd.
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Operating Business Segments
9.6.4. Product Portfolio
9.7. Lg Life Sciences
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Operating Business Segments
9.7.4. Product Portfolio
9.8. Cadila Pharmaceuticals Limited
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Operating Business Segments
9.8.4. Product Portfolio
9.9. Bourn Hall Clinic
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Product Portfolio
9.9.4. Key Strategic Moves And Developments
9.10. Morpheus Life Sciences Pvt. Ltd.
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Product Portfolio
9.11. Southend Fertility And Ivf Centre
9.11.1. Company Overview
9.11.2. Company Snapshot
9.11.3. Product Portfolio
9.12. Nova Ivi Fertility
9.12.1. Company Overview
9.12.2. Company Snapshot
9.12.3. Product Portfolio
9.12.4. Key Strategic Moves And Developments
9.13. Bloom Fertility Center
9.13.1. Company Overview
9.13.2. Company Snapshot
9.13.3. Operating Business Segments
9.13.4. Product Portfolio
9.14. Manipal Fertility Hospital
9.14.1. Company Overview
9.14.2. Company Snapshot
9.14.3. Operating Business Segments
9.14.4. Product Portfolio
9.15. Cloudnine Hospitals
9.15.1. Company Overview
9.15.2. Company Snapshot
9.15.3. Operating Business Segments
9.15.4. Key Strategic Moves And Developments
9.15.5. Product Portfolio
Table 01. India Ivf And Iui Services Market Volume And Value, 2014–2023 (Thousand And $Million)
Table 02. Mumbai: Key Ivf Centers
Table 03. National Capital Region (Ncr): Key Ivf Centers
Table 04. Bengaluru: Key Ivf Centers
Table 05. Chennai: Key Ivf Centers
Table 06. Kolkata: Key Ivf Centers
Table 07. Hyderabad: Key Ivf Centers
Table 08. Pune: Key Ivf Centers
Table 09. India Ivf Market, By Gender, 2018–2026 (Thousand)
Table 10. India Ivf Market, By Gender, 2018–2026 ($Million)
Table 11. India Ivf And Iui Market, By Procedure, 2018–2026 (Thousand)
Table 12. India Ivf And Iui Market, By Procedure, 2018–2026 ($Million)
Table 13. India Ivf Services Market, By Cycle Type, 2018-2026 (Thousand)
Table 14. India Ivf Services Market, By Cycle Type, 2018-2026 ($Million)
Table 15. India Ivf Services Market, By End User, 2018–2026 (Thousand)
Table 16. India Ivf Services Market, By End User, 2018–2026 ($Million)
Table 17. India Ivf Market, By offering, 2018–2026 (Thousand)
Table 18. Gunsheela Hospital: Company Snapshot
Table 19. Gunasheela Hospital: Operating Segment
Table 20. Gunasheela Hospital: Product/Service Portfolio
Table 21. Mathrutva Fertility Center: Company Snapshot
Table 22. Mathrutva Fertility Center: Operating Segment
Table 23. Mathrutva Fertility Center: Product/Service Portfolio
Table 24. Milann- The Fertility Center: Company Snapshot
Table 25. Milann- The Fertility Center: Operating Segment
Table 26. Milann- The Fertility Center: Product/Service Portfolio
Table 27. Oasis Centre: Company Snapshot
Table 28. Oasis Centre: Operating Segments
Table 29. Oasis Centre: Product/Service Portfolio
Table 30. Sun Pharma: Company Snapshot
Table 31. Sun Pharma: Operating Segments
Table 32. Sun Pharma: Product Portfolio
Table 33. Labivf Asia Pte. Ltd.: Company Snapshot
Table 34. Labivf Asia Pte. Ltd.: Operating Segments
Table 35. Labivf Asia Pte. Ltd.: Product Portfolio
Table 36. Lg Life Sciences Ltd.: Company Snapshot
Table 37. Lg Life Sciences Ltd.: Operating Segments
Table 38. Lg Life Sciences Ltd.: Product Portfolio
Table 39. Cadila Pharmaceuticals: Company Snapshot
Table 40. Cadila Pharmaceuticals: Divisions
Table 41. Cadila Pharmaceuticals: Product Portfolio
Table 42. Bourn Hall Clinic: Company Snapshot
Table 43. Bourn Hall Clinic: Product/Service Portfolio
Table 44. Morpheus Ivf Fertility Center: Company Snapshot
Table 45. Morpheus Life Sciences Pvt. Ltd.: Product/Service Portfolio
Table 46. Southend Fertility And Ivf Centre: Company Snapshot
Table 47. Southend Fertility And Ivf Centre: Product/Service Portfolio
Table 48. Nova Ivi Fertility: Company Snapshot
Table 49. Nova Ivi Fertility: Product/Service Portfolio
Table 50. Bloom Fertility Centre: Company Snapshot
Table 51. Bloom Fertility Centre: Operating Segment
Table 52. Bloom Fertility Centre: Product. Service Portfolio
Table 53. Manipal Fertility Hoispital: Company Snapshot
Table 54. Manipal Fertility Hoispital: Operating Segment
Table 55. Manipal Fertility Hoispital: Product/ Service Portfolio
Table 56. Cloudnine Hospital: Company Snapshot
Table 57. Cloudnine Hospitals: Operating Segments
Table 58. Cloudnine Hospitals: Product/Service Portfolio
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
